Cilareach 500mg/500mg Injection
Marketer
Fusion Healthcare Pvt Ltd
Salt Composition
Imipenem (500mg) + Cilastatin (500mg)
Overview Cilareach 500mg/500mg Injection
Combiflox 500mg/500mg Injection, a dual-antibiotic formulation, targets severe bacterial infections. Its action combats infectious agents, preventing infection spread. Administration must be under a healthcare provider's direct supervision; adhere strictly to the prescribed schedule. Complete the entire treatment course, even with symptom improvement. Typical side effects include nausea, vomiting, diarrhea, and skin rashes. Injection site reactions (redness, swelling, pain) may occur but usually subside. Report worsening side effects immediately to your physician. Seek emergency care for allergic responses (rashes, itching, swelling, breathing difficulties). Inform your doctor of all current medications, including those for pre-existing conditions, before use. Pregnant or lactating individuals should consult their physician before initiating treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness.
Uses of Cilareach 500mg/500mg Injection
Life-threatening bacterial infections
Major Benefits of Cilareach 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cilareach 500mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use Cilareach 500mg/500mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Cilareach 500mg/500mg Injection works:
Cilareach, a 500mg/500mg injectable formulation, combines the antibiotic imipenem with cilastatin, a dehydropeptidase I inhibitor. Imipenem's antibacterial action disrupts bacterial cell wall synthesis, crucial for bacterial viability. Cilastatin safeguards imipenem's efficacy by inhibiting dehydropeptidase I, the enzyme responsible for its degradation. This dual mechanism extends imipenem's therapeutic presence within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cilareach 500mg/500mg Injection lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
The use of Cilareach 500mg/500mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Physician consultation is recommended.
Breast feedingSAFE IF PRESCRIBED
The administration of Cilareach 500mg/500mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Administering Cilareach 500mg/500mg Injection may induce adverse reactions potentially impairing driving capabilities. Certain side effects, including hallucinations (visual, auditory, or sensory), can impact a patient's ability to operate a vehicle.
KidneyCAUTION
Patients with kidney impairment should use Cilareach 500mg/500mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cilareach 500mg/500mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Cilareach 500mg/500mg Injection :
Should you inadvertently omit a scheduled dose of Cilareach 500mg/500mg Injection, seek advice from your physician.
Facts to Know About Cilareach 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently